genomic abnormalities

We help you improve your confidence in the genomic stability of your human cell lines so you gain time, credibility and quality in your final product. Strengthen your workflow with a cost-effective solution.

Target genomic abnormalities in human stem cells

Next generation quality control for cell therapy

Stem Genomics is a biotech company specialized in the development of innovative testing solutions for research scientists working on human stem cells. We help you assess the genomic stability of your cell lines with specific assays and recommended workflows for the cell type you work with.

Whether you work on Pluripotent Stem Cells (PSCs), Mesenchymal Stromal Cells (MSCs) or other types of human stem cells, we can perform various categories of tests and analyses suited to your specific needs.

Discover a range of straightforward tests dedicated to your cell type

Our flagship testing solution, iCS-digital™ PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. We can also perform the following tests for you: G-Banding karyotyping, mycoplasma detection, aneuploidy detection, Next Generation Sequencing or design customized assays to meet your requirements. 

All our tests will take into account the constraints related to the cell type you work with. With all the assays we perform, you will receive clear, straightforward reports to make it easier to understand the analysis and to support your decision-making process.

Benefit from our experience and expertise in stem cells

Founded in 2018, Stem Genomics is a spin-out of the Institute for Regenerative Medicine & Biotherapy (IRMB), co-founded by Professor John de Vos and Dr. Said Assou, experts in stem cell genomic integrity. To date, we have worked with over 150 clients worldwide.

Download this file immediately

Please enter your e-mail address.